CM Hospitalar S/A Share Price

Equities

VVEO3

BRVVEOACNOR0

Pharmaceuticals

Market Closed - Sao Paulo 21:06:00 26/04/2024 BST 5-day change 1st Jan Change
5.46 BRL -16.64% Intraday chart for CM Hospitalar S/A -13.88% -60.86%

Financials

Sales 2024 * 12.23B 2.39B 191B Sales 2025 * 13.42B 2.62B 210B Capitalization 1.75B 342M 27.35B
Net income 2024 * 414M 80.95M 6.48B Net income 2025 * 539M 105M 8.44B EV / Sales 2024 * 0.35 x
Net Debt 2024 * 2.48B 486M 38.86B Net Debt 2025 * 2.32B 453M 36.26B EV / Sales 2025 * 0.3 x
P/E ratio 2024 *
5.15 x
P/E ratio 2025 *
3.4 x
Employees 6,000
Yield 2024 *
8.29%
Yield 2025 *
6.5%
Free-Float 47.47%
More Fundamentals * Assessed data
Dynamic Chart
CM Hospitalar S/A Reports Earnings Results for the Full Year Ended December 31, 2023 CI
CM Hospitalar S/A Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
CM Hospitalar S/A(BOVESPA:VVEO3) added to Brazil Small Cap Index CI
CM Hospitalar S/A Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
CM Hospitalar S/A Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
CM Hospitalar S/A Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
CM Hospitalar S/A Reports Earnings Results for the Fourth Quarter Ended December 31, 2022 CI
CM Hospitalar S/A Reports Earnings Results for the Fourth Quarter Ended December 31, 2022 CI
CM Hospitalar S/A Reports Earnings Results for the Full Year Ended December 31, 2022 CI
CM Hospitalar S/A Reports Earnings Results for the Full Year Ended December 31, 2022 CI
CM Hospitalar S/A acquired remaining stake in Far.me. CI
CM Hospitalar S/A Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
CM Hospitalar S/A agreed to acquire Neve Industria e Comercio de Produtos Cirurgicos and Nutrifica Comercio de Nutricao Enteral e Parenteral for BRL 110 million. CI
CM Hospitalar S/A Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
Brazil's Viveo sees $23 mln EBITDA growth after multiple acquisitions RE
More news
1 day-16.64%
1 week-13.88%
Current month-11.22%
1 month-15.35%
3 months-51.47%
6 months-64.66%
Current year-60.86%
More quotes
1 week
5.37
Extreme 5.37
6.67
1 month
5.37
Extreme 5.37
7.40
Current year
5.37
Extreme 5.37
14.09
1 year
5.37
Extreme 5.37
22.61
3 years
5.37
Extreme 5.37
27.90
5 years
5.37
Extreme 5.37
27.90
10 years
5.37
Extreme 5.37
27.90
More quotes
Managers TitleAgeSince
Chief Executive Officer 44 24/08/21
Director of Finance/CFO 44 31/01/19
Chief Operating Officer 53 31/12/10
Members of the board TitleAgeSince
Director/Board Member 44 28/04/22
Chairman 45 31/12/15
Director/Board Member 45 31/07/22
More insiders
Date Price Change Volume
26/04/24 5.46 +0.37% 1,621,800
25/04/24 5.44 -6.69% 1,235,100
24/04/24 5.83 -9.89% 1,196,300
23/04/24 6.47 -1.22% 649,700
22/04/24 6.55 +3.31% 545,200

Delayed Quote Sao Paulo, April 26, 2024 at 09:06 pm

More quotes
CM Hospitalar SA, formerly known as a CM Hospitalar Ltda, is a Brazil-based public company which engages in the wholesale trade of medicines, drugs, and hospital supplies. The Company operates mainly in export, import, production, representation, storage, distribution, and shipment of medicines, including special control and wholesale trade in general, acting mainly in the trade in health products, as a middleman between industries and hospitals, clinics, home cares and health institutions in the private and public market, in addition to participating in other investments. It operates throughout Brazil with a commercial and logistical structure. The Company's medium and long-term planning encompasses the acquisition of companies from the segment and an important commercial strengthening throughout Brazil, expanding its position in the distribution of medicines and hospital supplies.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
9
Last Close Price
5.46 BRL
Average target price
16.51 BRL
Spread / Average Target
+202.40%
Consensus